Search

Search Constraints

You searched for: Author/Creator Marques, Laura

Search Results

2. Children living with HIV in Europe: do migrants have worse treatment outcomes?. Issue 2 (1st October 2021)

3. Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial. Issue 9 (September 2022)

4. Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis. Issue 3 (7th March 2022)

5. Immunisation practices in centres caring for children with perinatally acquired HIV: A call for harmonisation. Issue 46 (4th November 2016)

6. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration. Issue 2 (February 2019)

8. Membranoproliferative Glomerulonephritis and X-Linked Agammaglobulinemia: An Uncommon Association. (4th March 2014)

9. Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial. Issue 9 (September 2022)

10. Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand. Issue 3 (10th June 2022)